Arkema S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARKAY research report →
Price Chart
About the company
Arkema SA engages in manufacturing and supplying chemical products. It operates through the following segments: Adhesive Solutions, Advanced Materials, Coating Solutions, Intermediates, and Corporate. The Adhesive Solutions segment supplies technologies used in building activities for businesses and individuals, including sealants, tile and flooring adhesives and waterproofing systems, and technologies.
- CEO
- Thierry le Hénaff
- IPO
- 2006
- Employees
- 20,648
- HQ
- Puteaux, MD, FR
Get TickerSpark's AI analysis on ARKAY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.20B
- P/E
- 103.68
- Fwd P/E
- 14.31
- PEG
- -1.34
- P/S
- 0.50
- P/B
- 0.89
- EV/EBITDA
- 6.26
- Div Yield
- 6.09%
- Gross Margin
- 17.83%
- Op Margin
- 4.54%
- Net Margin
- 0.67%
- ROE
- 0.92%
- ROIC
- 1.33%
Latest fiscal year · YoY change
- Revenue
- $8.71B-8.7%
- Gross Profit
- $1.55B-20.0%
- Op Income
- $403.42M
- Net Income
- $60.51M-82.9%
- EPS
- $0.80-82.3%
- OCF Growth
- -16.6%
- FCF Growth
- -8.3%
- 52W High
- $79.36
- 52W Low
- $56.28
- 50D MA
- $66.39
- 200D MA
- $65.82
- Beta
- 0.95
- RSI (14)
- 50
- Avg Volume
- 1.14K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Arkema’s Q1 showed stable volumes and better March momentum, but earnings were pressured by currency and weak Europe/U.S. demand, while management reaffirmed slight constant-currency EBITDA growth for 2026.· May 6, 2026
- Q1 revenue was EUR 2.2 billion, down 8.4% year on year, with volumes broadly stable and March improving after a soft January-February.
- Q1 EBITDA was EUR 283 million, down year on year but up 14% versus Q4 2025; currency was a roughly EUR 20 million headwind.
- Specialty Materials volumes rose 1.5%, led by Coating Solutions, Advanced Materials in attractive end markets, and strong growth in batteries, sport, 3D printing and healthcare.
- Coating Solutions improved EBITDA margin by 100 bps to 13%; PIAM posted more than 30% EBITDA growth in local currency with a 35% margin.
- Management kept 2026 guidance for slight EBITDA growth at constant exchange rates and said Q2 should be comparable to Q2 2025.
- Capex and working capital remained disciplined, with 2026 capex still targeted at EUR 600 million and net debt at EUR 3.3 billion.
Arkema reported Q1 2026 revenue of EUR 2.2 billion, down 8.4% year on year, with a negative 5.1% currency effect and a 3% price decline; volumes were broadly stable. Q1 EBITDA was EUR 283 million, with roughly EUR 20 million of negative FX impact. By segment, EBITDA was EUR 89 million for Adhesive Solutions, EUR 139 million for Advanced Materials, EUR 51 million for Coating Solutions, and EUR 33 million for Primary Materials. Adjusted net income was EUR 65 million, or EUR 0.86 per share; recurring EBIT was EUR 118 million and the REBIT margin was 5.4%. Recurring cash flow was minus EUR 95 million, working capital ratio was 16.3%, capex was EUR 75 million, net debt and hybrid bonds were EUR 3.3 billion, and net debt/last-12-month EBITDA was 2.8x. Management confirmed full-year 2026 guidance for slight EBITDA growth at constant exchange rates and reiterated EUR 600 million of capex for the year. For Q2, management said EBITDA should be comparable to Q2 2025 and noted improving momentum in Advanced Materials, aided by HPP, as well as pricing actions to offset raw material, energy, and logistics inflation.
Thierry Le Hénaff framed the quarter as resilient in a difficult setting, with soft demand in Europe and the U.S. but solid momentum in Asia and strong March improvement. He emphasized Arkema’s diversified portfolio and said the Middle East conflict should be roughly neutral overall for the group, though it creates both costs and some supply-demand support in places. He also highlighted continued execution on growth projects, especially PVDF, HPP, and Rilsan Clear, and pointed to Arkema’s 20-year transformation into a more profitable specialty materials company.
Marie-José Donsion said Q1 revenue fell to EUR 2.2 billion, down 8.4% year on year, mainly because of a 5.1% FX headwind and a 3% price decline, while volumes were broadly stable. She detailed EBITDA of EUR 283 million, adjusted net income of EUR 65 million, recurring EBIT of EUR 118 million, and nonrecurring items of EUR 45 million, including EUR 34 million of PPA depreciation and EUR 11 million of one-off charges. On cash, she cited recurring cash flow of minus EUR 95 million, working capital at 16.3% of annualized sales, capex of EUR 75 million, and net debt and hybrid bonds of EUR 3.3 billion, with leverage at 2.8x; she also said the EUR 600 million full-year capex target remains intact.
Analysts focused on how Middle East disruption might change the mix between upstream and downstream businesses, whether March strength reflected prebuying, and how management sees Advanced Materials mix and the new China PVDF investment. Management said the portfolio is balanced and that Q2 should see acrylics improve on tighter supply-demand conditions, while Advanced Materials should improve sequentially as HPP ramps and Performance Additives faces more pressure from sulfur-related cost inflation. On PVDF, Thierry Le Hénaff said Arkema remains comfortable investing because PVDF has long been a growth and profitability engine, especially in high-end applications like semiconductors, batteries, and cables. He also said March may have included some prebuying, but April was continuing in line with March, supporting the view that Q2 EBITDA should be comparable to last year.
The positive case from the call is that Arkema held volumes stable in a weak macro environment and saw a clear March pickup, especially in Specialty Materials. Management also pointed to improving earnings momentum in Q2 from HPP, acrylics, and growth projects such as PVDF and Rilsan Clear, while reaffirming full-year guidance.
The main risks discussed were weak demand in Europe and the U.S., currency pressure, and uncertainty from the Middle East conflict, which is already lifting raw materials, energy, and logistics costs. Management also acknowledged timing lags in passing through costs, especially in downstream businesses, and said parts of Advanced Materials and Performance Additives remain mixed or under pressure.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 100.0%
- Shares Outstanding
- 75.68M
- Float Shares
- 75.68M
of shares held by institutions
8 13F filers
Congressional trading
Senate and House stock disclosures for ARKAY, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Daniel GoldmanHouse · NY10 | Sell | Jul 10, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Private Capital Group, LLC | 72 | ▼ 9 |
| Freedman Financial Associates, Inc. | 63 | 0 |
| Crescent Capital Consulting, LLC | 25 | 0 |
Our ARKAY coverage
Recent articles, reports, and earnings notes.
No research on ARKAY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ARKAY report →Arkema S.A. (ARKAY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 30
ARKAY Beverages Seeks Social Media Employees to Manage Facebook, X, Instagram, TikTok, LinkedIn and Global Digital Engagement
globenewswire.com · Jun 2
Financial Contrast: Shin-Etsu Chemical (OTCMKTS:SHECY) versus Arkema (OTCMKTS:ARKAY)
defenseworld.net · Apr 7
Arkema Announces Expansion of Kynar PVDF Production Capacity in China
zacks.com · Mar 17
Arkema (OTCMKTS:ARKAY) Shares Gap Down on Analyst Downgrade
defenseworld.net · Mar 3
Arkema S.A. (ARKAY) Q4 2025 Earnings Call Transcript
seekingalpha.com · Feb 26
Arkema SA (OTCMKTS:ARKAY) Sees Large Decline in Short Interest
defenseworld.net · Feb 11
ARKAY's New Rilsan Polyamide Unit Begins Operations in Singapore
zacks.com · Jan 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.